Reclassification of marijuana opens doors for much-needed medical research into the benefits and risks of the drug
(BINGHAMTON, NY) When the U.S. Department of Justice moved to reclassify medical marijuana to a Schedule III drug on April 23, 2026, it set the stage for a vast amount of medical research that has been hobbled for decades by its more restrictive Schedule I classification.
The Justice Department
